Surrozen, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SRZN research report →
About the company
Surrozen, Inc. , a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.
- CEO
- Craig Parker
- IPO
- 2021
- Employees
- 42
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $186.34M
- P/E
- -0.60
- P/S
- 24.86
- P/B
- -0.98
- EV/EBITDA
- -0.25
- Div Yield
- 0.00%
- Gross Margin
- 99.13%
- Op Margin
- -573.75%
- Net Margin
- -4571.14%
- ROE
- 309.79%
- ROIC
- -38.03%
- Revenue
- $3.48M · -67.37%
- Net Income
- $-242,026,000 · -280.76%
- EPS
- $-32.37 · -49.38%
- Op Income
- $-42,092,000
- FCF YoY
- -72.04%
- 52W High
- $35.00
- 52W Low
- $8.08
- 50D MA
- $26.88
- 200D MA
- $21.91
- Beta
- 0.51
- Avg Volume
- 131.89K
Get TickerSpark's AI analysis on SRZN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 15, 26 | Maleki Andrew Pedrum | other | 607 |
| Jun 15, 26 | Li Yang | other | 1,666 |
| Jun 15, 26 | Williams Charles O | other | 1,666 |
| Jun 15, 26 | Parker Craig C | other | 1,622 |
| May 13, 26 | Kutzkey Tim | other | 5,550 |
| May 13, 26 | Rothenberg Mace | other | 5,550 |
| May 13, 26 | WOODHOUSE DAVID J | other | 5,550 |
| May 13, 26 | Haak-Frendscho Mary | other | 5,550 |
| May 13, 26 | CHAI CHRISTOPHER Y | other | 5,550 |
| May 13, 26 | BJERKHOLT ERIC | other | 5,550 |
Our SRZN coverage
Recent articles, reports, and earnings notes.
No research on SRZN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SRZN report →Similar companies
Peers in the same neighborhood.